Sartorius Stedim Biotech (SSB) has developed a technology platform that will allow customers to adopt a Quality by Design (QbD) approach in which they build quality into their biological products by combining the high-throughput mini bioreactors with data analysis and knowledge management tools so that robust and well-characterized processes can be scaled up at the first attempt. The company says despite considerable interest, full QbD adoption by the biopharmaceutical industry has yet to occ...